Literature DB >> 17541620

Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Hans-J Welkoborsky1, Roland S Jacob, Mike L Hinni.   

Abstract

In the clinical setting, pediatric cholesteatomas frequently behave more aggressively than similar lesions in adults. The reason for the difference in behavior is still unclear. The purpose of the present study was to investigate the cell to cell and epithelial-stroma interaction of acquired cholesteatoma in adults and children and search for differences on the cellular level, which might explain the different behavior of these lesions. Operative specimens of 54 patients [40 adults (average age of 39.7 years), 14 children (average age of 8.3 years)] who underwent primary surgery for an acquired cholesteatoma of the middle ear were examined by histopathology and DNA-image cytometry (DNA-ICM). Immunohistochemical investigations included expression of proliferation markers (proliferation cell nuclear antigen and MIB-1) along with cell surface markers reflecting the cell-to-cell interaction (i.e. alpha1beta6-integrin, E-cadherin, I-CAM = CD54), and the epithelial to stroma interaction (i.e. alphav and beta3 intergin chains, V-CAM = CD106, CD44v6 and fibronectin). Pediatric cholesteatomas demonstrated higher incidence of acute inflammation and more extensive disease relative to those from the adults. Indices of DNA-ICM, however, revealed normal diploid DNA content in both groups. Higher proliferation scores occurred in the pediatric group compared to adult cholesteatoma. Cell surface markers and cell adhesion molecules were equally expressed in both groups except alpha1beta6-integrin and fibronectin, which were over expressed in pediatric cholesteatomas. Statistically, however, these differences showed only a trend towards significance. According to the results of the present study, pediatric and adult cholesteatomas do not show any marked differences on the cellular level. Thus the observed clinical more aggressive behavior of pediatric cholesteatoma is likely due to other secondary factors such as more intense inflammation, disturbed middle ear ventilation or the diminished calcium salt content of pediatric bone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541620     DOI: 10.1007/s00405-007-0328-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  52 in total

1.  Significance of trisomy 7 related to PCNA index in cholesteatoma.

Authors:  A Lavezzi; M Mantovani; A Cazzulo; P Turconi; L Matturri
Journal:  Am J Otolaryngol       Date:  1998 Mar-Apr       Impact factor: 1.808

2.  Chromosomal localization of the human proliferating cell nuclear antigen (PCNA) gene to or close to 20p12 by in situ hybridization.

Authors:  V V Rao; S Schnittger; I Hansmann
Journal:  Cytogenet Cell Genet       Date:  1991

3.  Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin.

Authors:  A R Banerjee; J L Jones; J P Birchall; D G Powe
Journal:  Otol Neurotol       Date:  2001-09       Impact factor: 2.311

4.  Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.

Authors:  K V Sastry; S C Sharma; S B Mann; N K Ganguly; N K Panda
Journal:  Am J Otol       Date:  1999-03

5.  Cloning, sequencing, and chromosomal localization of two tandemly arranged human pseudogenes for the proliferating cell nuclear antigen (PCNA).

Authors:  Y Taniguchi; Y Katsumata; S Koido; H Suemizu; S Yoshimura; T Moriuchi; K Okumura; K Kagotani; H Taguchi; T Imanishi; T Gojobori; H Inoko
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

6.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

7.  [Clinic feathers of cholesteatoma in children].

Authors:  Dongyan Huang; Dongyi Han
Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi       Date:  2003-04

Review 8.  High levels of fibronectin in the stroma of aural cholesteatoma.

Authors:  V Schilling; A Holly; J Bujía; P Schulz; E Kastenbauer
Journal:  Am J Otolaryngol       Date:  1995 Jul-Aug       Impact factor: 1.808

9.  [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].

Authors:  S Lang; A Nerlich; I Wiest; M Schreiner
Journal:  Laryngorhinootologie       Date:  1994-07       Impact factor: 1.057

10.  Integrin expression in middle ear cholesteatoma.

Authors:  S Dallari; A Cavani; G Bergamini; G Girolomoni
Journal:  Acta Otolaryngol       Date:  1994-03       Impact factor: 1.494

View more
  4 in total

1.  Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions.

Authors:  M Duderstadt; Christine Förster; H-J Welkoborsky; H Ostertag
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-24       Impact factor: 2.503

2.  Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.

Authors:  Dong Wook Lee; Jae Ho Chung; Seung Hwan Lee; Chul Won Park; Sung-Ho Kang; Young Ha Oh; Ju Yeon Pyo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

3.  [Current aspects of paediatric cholesteatomas].

Authors:  J P Thomas; S Volkenstein; A Minovi; S Dazert
Journal:  HNO       Date:  2013-05       Impact factor: 1.284

4.  The c-MYC protooncogene expression in cholesteatoma.

Authors:  Enikő Palkó; Szilárd Póliska; Zsuzsanna Csákányi; Gábor Katona; Tamás Karosi; Frigyes Helfferich; András Penyige; István Sziklai
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.